相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
Connie W. Tsao et al.
CIRCULATION (2023)
Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial
Shahin Merat et al.
EUROPEAN HEART JOURNAL (2022)
Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials
Shreya Rao et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2022)
Fixed-Dose Combination (Polypill) for Cardiovascular Disease Prevention: A Meta-Analysis
Abdelrahman I. Abushouk et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2022)
Polypill for cardiovascular disease prevention: Systematic review and meta-analysis of randomized controlled trials
Mohamed M. G. Mohamed et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)
Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review
Reza Jahangiri et al.
PLOS ONE (2022)
A polypill improves secondary prevention of heart attack
H. Vaillant et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)
Polypill Strategy in Secondary Cardiovascular Prevention
Jose M. Castellano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Polypill with or without Aspirin in Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis
Sean McGrath et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2020)
Multicap to improve adherence after acute coronary syndromes: results of a randomized controlled clinical trial
Javier Mariani et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2020)
Mortality From Ischemic Heart Disease Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration
Alexandra N. Nowbar et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial
Gholamreza Roshandel et al.
LANCET (2019)
Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial
Kavita Singh et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition
Dorairaj Prabhakaran et al.
LANCET (2018)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Effect of a Cardiovascular Polypill Strategy on Pill Burden
Michael Truelove et al.
CARDIOVASCULAR THERAPEUTICS (2015)
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk
Anushka Patel et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
A Polypill Strategy to Improve Adherence Results From the FOCUS Project
Jose M. Castellano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care
Vanessa Selak et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
Rajiv Chowdhury et al.
EUROPEAN HEART JOURNAL (2013)
Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD The UMPIRE Randomized Clinical Trial
Simon Thom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
Salim Yusuf et al.
LANCET (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Medication Adherence in Cardiovascular Disease
Steven Baroletti et al.
CIRCULATION (2010)
Are There Effects of Renin–Angiotensin System Antagonists Beyond Blood Pressure Control?
George Bakris
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial
S. Yusuf et al.
LANCET (2009)
A strategy to reduce cardiovascular disease by more than 80%
NJ Wald et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
